Abbott Laboratories News Headlines

ABT 
$43.69
*  
0.31
0.71%
Get ABT Alerts
*Delayed - data as of Sep. 18, 2014  -  Find a broker to begin trading ABT now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ABT After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Abbott Labs (ABT) to Initiate New Trial on Absorb - Analyst Blog
9/17/2014 5:05:00 PM - Zacks.com

JNK, RXL: Big ETF Outflows
9/17/2014 12:03:37 PM - BNK Invest

Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away
9/16/2014 2:01:00 PM - Seeking Alpha

10 Dividend Growth Stocks Giving Investors More Money
9/15/2014 11:16:00 PM - Seeking Alpha

Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog
9/15/2014 5:20:00 PM - Zacks.com

Update: Abbott To Invest $60 Million In An Intraocular Lens Plant In Malaysia
9/15/2014 3:00:00 PM - Seeking Alpha

Notable ETF Outflow Detected - SSO, MMM, ABT, ABBV
9/15/2014 1:04:55 PM - BNK Invest

Abbott Begins ABSORB IV Trial To Test Quality Of Life & Cost Savings Of BVS
9/15/2014 9:51:00 AM - RTT News

Attunity, Ltd. (ATTU) in Focus: Stock Adds 5.2% in Session - Tale of the Tape
9/15/2014 9:18:00 AM - Zacks.com

Abbott's Dissolving Heart Device Shows Positive Study Results
9/14/2014 4:25:00 PM - RTT News

AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog
9/12/2014 5:05:00 PM - Zacks.com

Abbott Labs (ABT) to Repurchase Shares for $3B - Analyst Blog
9/12/2014 4:50:00 PM - Zacks.com

Daily Dividend Report: INTC, ABT, TJX, BXP, RL, SLG, HUN, CBI, DRI, OCR
9/12/2014 1:01:30 PM - BNK Invest

Stocks And Funds With The Most Size (Small-Cap) Risk
9/12/2014 8:04:00 AM - Seeking Alpha

Evaluating GlaxoSmithKline's Intrinsic Value
9/12/2014 7:38:00 AM - Seeking Alpha

Mylan to Acquire U.S. Rights to Arixtra for up to $300M - Analyst Blog
9/11/2014 5:20:00 PM - Zacks.com

FDA Approves Orexigen Therapeutics Inc.'s Goldilocks Obesity Drug
9/11/2014 4:46:01 PM - Motley Fool

Abbott Announces New $3 Bln Stock Buyback Program
9/11/2014 2:30:00 PM - RTT News

Abbott Laboratories (ABT) Declares Quarterly Dividend, Announces Share Buyback
9/11/2014 2:29:00 PM - TheStreet

Abbott Is Getting Expensive On A Fundamental Basis
9/11/2014 10:13:00 AM - Seeking Alpha

ACWI, RXL: Big ETF Inflows
9/9/2014 12:08:49 PM - BNK Invest

FTC Sues AbbVie For Illegally Blocking Generic Version Of AndroGel
9/9/2014 4:00:00 AM - RTT News

What Price Dividend Aristocracy? Assessing The Dividend Aristocrats And The NOBL ETF (Part 2)
9/8/2014 3:57:00 PM - Seeking Alpha

Noteworthy ETF Outflows: SSO, MMM, ABT, ABBV
9/8/2014 11:41:43 AM - BNK Invest

What Price Dividend Aristocracy? The Dividend Aristocrats And Their Fair Values (Part 1)
9/5/2014 8:44:00 PM - Seeking Alpha